Cardiovascular risk associated with the use of glitazones, metformin and sufonylureas: meta-analysis of published observational studies

BACKGROUND: The results of observational studies evaluating and comparing the cardiovascular safety of glitazones, metformin and sufonylureas are inconsistent.To conduct and evaluate heterogeneity in a meta-analysis of observational studies on the risk of acute myocardial infarction (AMI) or stroke...

Descripción completa

Detalles Bibliográficos
Autores principales: Pladevall, Manel, Riera-Guardia, Nuria, Margulis, Andrea V, Varas-Lorenzo, Cristina, Calingaert, Brian, Perez-Gutthann, Susana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714432/
https://www.ncbi.nlm.nih.gov/pubmed/26769243
http://dx.doi.org/10.1186/s12872-016-0187-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714432/
https://www.ncbi.nlm.nih.gov/pubmed/26769243
http://dx.doi.org/10.1186/s12872-016-0187-5

Ejemplares similares